(Q37385188)

20 August 2017

1 reference

title

Metabolic syndrome associated with HIV and highly active antiretroviral therapy (English)

1 reference

20 August 2017

0 references

anti-retroviral agent

0 references

1 reference

1

Giuseppe Barbaro

1 reference

20 August 2017

Gialuca Iacobellis

2

1 reference

20 August 2017

1 February 2009

1 reference

20 August 2017

Current diabetes report

1 reference

20 August 2017

9

1 reference

20 August 2017

1

1 reference

20 August 2017

37-42

1 reference

https://scigraph.springernature.com/pub.10.1007/s11892-009-0008-7

20 August 2017

0 references

cites work

Use of human immunodeficiency virus-1 protease inhibitors is associated with atherogenic lipoprotein changes and endothelial dysfunction

1 reference

Crossref

https://api.crossref.org/works/10.1007%2FS11892-009-0008-7

Metabolic effects of rosiglitazone in HIV lipodystrophy: a randomized, controlled trial

21 January 2018

1 reference

Crossref

https://api.crossref.org/works/10.1007%2FS11892-009-0008-7

Hypertension among HIV patients: prevalence and relationships to insulin resistance and metabolic syndrome

21 January 2018

1 reference

12 December 2020

Epicardial adipose tissue is related to carotid intima-media thickness and visceral adiposity in HIV-infected patients with highly active antiretroviral therapy-associated metabolic syndrome

1 reference

12 December 2020

Epidemiology of thrombosis in HIV-infected individuals. The Adult/Adolescent Spectrum of HIV Disease Project

1 reference

12 December 2020

Cardiovascular and cerebrovascular events in patients treated for human immunodeficiency virus infection

1 reference

12 December 2020

A syndrome of peripheral lipodystrophy, hyperlipidaemia and insulin resistance in patients receiving HIV protease inhibitors

1 reference

12 December 2020

HIV protease inhibitor ritonavir induces cytotoxicity of human endothelial cells

1 reference

12 December 2020

Apoprotein c-III and E-containing lipoparticles are markedly increased in HIV-infected patients treated with protease inhibitors: association with the development of lipodystrophy

1 reference

12 December 2020

Premature atherosclerosis in HIV-infected individuals--focus on protease inhibitor therapy

1 reference

12 December 2020

Subclinical carotid atherosclerosis in HIV-infected patients: role of combination antiretroviral therapy

1 reference

12 December 2020

Pathogenesis of HIV-1-protease inhibitor-associated peripheral lipodystrophy, hyperlipidaemia, and insulin resistance.

1 reference

12 December 2020

Metabolic syndrome, cardiovascular disease and type 2 diabetes mellitus after initiation of antiretroviral therapy in HIV infection

1 reference

12 December 2020

Class of Antiretroviral Drugs and the Risk of Myocardial Infarction

1 reference

12 December 2020

Comparison of rosiglitazone and metformin for treating HIV lipodystrophy: a randomized trial

1 reference

12 December 2020

Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III) final report

1 reference

12 December 2020

Cardiovascular risk and body-fat abnormalities in HIV-infected adults

1 reference

12 December 2020

An interaction between apo C-III variants and protease inhibitors contributes to high triglyceride/low HDL levels in treated HIV patients

1 reference

12 December 2020

The pavia consensus statement

1 reference

12 December 2020

The effects of recombinant human growth hormone on body composition and glucose metabolism in HIV-infected patients with fat accumulation

1 reference

12 December 2020

Carotid artery intima-media thickness and HIV infection: traditional risk factors overshadow impact of protease inhibitor exposure

1 reference

12 December 2020

The HIV-1 nucleoside reverse transcriptase inhibitors stavudine and zidovudine alter adipocyte functions in vitro

1 reference

12 December 2020

HAART drugs induce mitochondrial damage and intercellular gaps and gp120 causes apoptosis

1 reference

12 December 2020

Evaluation of the risk factors associated with lipodystrophy development in a cohort of HIV-positive patients

1 reference

12 December 2020

Some HIV protease inhibitors alter lamin A/C maturation and stability, SREBP-1 nuclear localization and adipocyte differentiation

1 reference

12 December 2020

An open-label, prospective, observational study of the incidence of coronary artery disease in patients with hiv infection receiving highly active antiretroviral therapy

1 reference

12 December 2020

Premature lesions of the carotid vessels in HIV-1-infected patients treated with protease inhibitors.

1 reference

12 December 2020

Hypoadiponectinemia is associated with insulin resistance, hypertriglyceridemia, and fat redistribution in human immunodeficiency virus-infected patients treated with highly active antiretroviral therapy

1 reference

12 December 2020

Progression of atherosclerosis as assessed by carotid intima-media thickness in patients with HIV infection

1 reference

12 December 2020

Assessment of growth hormone dynamics in human immunodeficiency virus-related lipodystrophy

1 reference

12 December 2020

Lipodystrophy associated with highly active anti-retroviral therapy for HIV infection: the adipocyte as a target of anti-retroviral-induced mitochondrial toxicity.

1 reference

12 December 2020

Prevalence of metabolic syndrome in HIV-infected patients receiving highly active antiretroviral therapy using International Diabetes Foundation and Adult Treatment Panel III criteria: associations with insulin resistance, disturbed body fat compart

1 reference

12 December 2020

Adipocytes targets and actors in the pathogenesis of HIV-associated lipodystrophy and metabolic alterations.

1 reference

12 December 2020

Increased risk of myocardial infarction with duration of protease inhibitor therapy in HIV-infected men.

1 reference

12 December 2020

Improvements in lipoatrophy, mitochondrial DNA levels and fat apoptosis after replacing stavudine with abacavir or zidovudine

1 reference

12 December 2020

A randomized, placebo-controlled trial of rosiglitazone for HIV-related lipoatrophy.

1 reference

12 December 2020

Relation of subepicardial adipose tissue to carotid intima-media thickness in patients with human immunodeficiency virus

1 reference

12 December 2020

Elevated blood pressure in subjects with lipodystrophy

1 reference

12 December 2020

No effect of rosiglitazone for treatment of HIV-1 lipoatrophy: randomised, double-blind, placebo-controlled trial.

1 reference

12 December 2020

Protease inhibitors and cardiovascular outcomes in patients with HIV-1

1 reference

12 December 2020

HIV-associated renal diseases and highly active antiretroviral therapy-induced nephropathy

1 reference

12 December 2020

Serum adiponectin and leptin levels in patients with lipodystrophies

1 reference

12 December 2020

Increased PAI-1 and tPA antigen levels are reduced with metformin therapy in HIV-infected patients with fat redistribution and insulin resistance

1 reference

12 December 2020

Serum adipocytokines are related to lipodystrophy and metabolic disorders in HIV-infected men under antiretroviral therapy

1 reference

12 December 2020

Acute brachial artery thrombosis as the initial manifestation of human immunodeficiency virus infection

1 reference

12 December 2020

Antiretroviral nucleosides, deoxynucleotide carrier and mitochondrial DNA: evidence supporting the DNA pol gamma hypothesis.

1 reference

12 December 2020

Guidelines for the Evaluation and Management of Dyslipidemia in Human Immunodeficiency Virus (HIV)-Infected Adults Receiving Antiretroviral Therapy: Recommendations of the HIV Medicine Association of the Infectious Disease Society of America and the

1 reference

12 December 2020

Association of severe insulin resistance with both loss of limb fat and elevated serum tumor necrosis factor receptor levels in HIV lipodystrophy.

1 reference

12 December 2020

10.1007/S11892-009-0008-7

Identifiers

DOI

1 reference

20 August 2017

1 reference

PubMed ID

19192423